Hydrolytic Bioactivation
Hydrolytic Bioactivation is a bioprecursor prodrug activation mechanism in which a pharmacologically inactive precursor undergoes enzymatic or chemical hydrolysis to release the active drug moiety, distinguished from other bioactivation pathways by its reliance on cleavage of functional groups via hydrolytic reactions.
17
Publications
828
Citations
100
Authors
34
Institutions
Publications per year
2017–2026
4
Parents
17
Silvia Pfeiffer, Eva Leopold, Kurt Schmidt et al. · British Journal of Pharmacology · 1996 · 236 citations · Full text
Laurent Maveyraud, Lionel Mourey, Lakshmi P. Kotra et al. · Journal of the American Chemical Society · 1998 · 149 citations · Full text
1–5 of 17
100
2
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 100
34
Daiichi-Sankyo (Japan)
Tokyo, Japan
2 h-index
10 publications
188 citations

Cairo University
Giza, Egypt
1 h-index
1 publications
14 citations
Shanghai Institute of Materia Medica
Pudong, China
1 h-index
3 publications
84 citations

University of Debrecen
Debrecen, Hungary
1 h-index
1 publications
19 citations
Bristol-Myers Squibb (United States)
New York, United States
1 h-index
11 publications
143 citations

University of Toronto
Toronto, Canada
1 h-index
3 publications
60 citations
Daiichi Sankyo (Germany)
Munich, Germany
1 h-index
9 publications
153 citations

King Saud University
Riyadh, Saudi Arabia
1 h-index
3 publications
42 citations
1–8 of 34
2 publications · 52 citations
2
h-index
TAAP · 1 publications · 20 citations
1
h-index
1 publications · 17 citations
1
h-index
1 publications · 13 citations
1
h-index
1 publications · 13 citations
1
h-index
1–5